XyloCor Therapeutics

Phlox Therapeutics

This company develops RNA-based gene therapies to treat patients with rare genetic heart diseases, including cardiomyopathies and laminopathies.

Nuevocor

Nuevocor develops gene therapies for patients with genetic cardiomyopathies by addressing mechanical defects through its proprietary mechanobiology platform.

Lexeo Therapeutics

This clinical-stage company develops gene therapies for patients with genetically defined cardiovascular diseases and Alzheimer's disease.

Corlieve Therapeutics

The company develops gene therapies for patients with refractory temporal lobe epilepsy and other severe neurological disorders.

CorFlow Therapeutics

This medical device company develops a platform to diagnose and treat microvascular obstruction in heart attack patients for interventional cardiologists.

Rocket Pharma

This company develops gene therapies for patients with rare and devastating genetic cardiovascular and haematological diseases.

ProCorde AG

This cardiovascular-focused company develops therapies for thrombosis and vascular dysfunction to treat patients suffering from coronary artery disease and other cardiovascular pathologies.

Cardior

This company develops RNA-based therapeutics designed to prevent, repair and reverse heart diseases for patients with cardiac dysfunctions.